EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hyperbaric Oxygen Therapy Alleviates Paclitaxel-Induced Peripheral Neuropathy Involving Suppressing TLR4-MyD88-NF-κB Signaling Pathway

Shih-Hung Wang iD, Shu-Hung Huang iD, Meng-Chien Hsieh, I-Cheng Lu iD, Ping-Ruey Chou, Ming-Hong Tai, Sheng-Hua Wu iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24065379 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Shih-Hung Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan. Hauptthemen laut MEDLINE: Hyperbaric Oxygenation, Peripheral Nervous System Diseases, Antineoplastic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology of Taiwan, Kaohsiung Medical University, Kaohsiung Medical University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Paclitaxel (PAC) results in long-term chemotherapy-induced peripheral neuropathy (CIPN). The coexpression of transient receptor potential vanilloid 1 (TRPV1) and Toll-like receptor 4 (TLR4) in the nervous system plays an essential role in mediating CIPN. In this study, we used a TLR4 agonist (lipopolysaccharide, LPS) and a TLR4 antagonist (TAK-242) in the CIPN rat model to investigate the role of TLR4-MyD88 signaling in the antinociceptive effects of hyper-baric oxygen therapy (HBOT). All rats, except a control group, received PAC to induce CIPN. Aside from the PAC group, four residual groups were treated with either LPS or TAK-242, and two of them received an additional one-week HBOT (PAC/LPS/HBOT and PAC/TAK-242/HBOT group). Mechanical allodynia and thermal hyperalgesia were then assessed. The expressions of TRPV1, TLR4 and its downstream signaling molecule, MyD88, were investigated. The mechanical and thermal tests revealed that HBOT and TAK-242 alleviated behavioral signs of CIPN. Immunofluorescence in the spinal cord dorsal horn and dorsal root ganglion revealed that TLR4 overexpression in PAC- and PAC/LPS-treated rats was significantly downregulated after HBOT and TAK-242. Additionally, Western blots showed a significant reduction in TLR4, TRPV1, MyD88 and NF-κB. Therefore, we suggest that HBOT may alleviate CIPN by modulating the TLR4-MyD88-NF-κB pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperbaric OxygenationPeripheral Nervous System DiseasesAntineoplastic AgentsRatsAnimalsPaclitaxelNF-kappa BMyeloid Differentiation Factor 88LipopolysaccharidesToll-Like Receptor 4Rats, Sprague-DawleySignal TransductionHyperalgesiaSulfonamides

Stichwörter der Autor:innen

PaclitaxelToll-like receptor 4chemotherapy-induced peripheral neuropathyhyperbaric oxygen therapymyeloid differentiation factor 88 (MyD88)

Substanzen

PaclitaxelNF-kappa BMyeloid Differentiation Factor 88LipopolysaccharidesToll-Like Receptor 4Antineoplastic Agentsethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylateSulfonamidesTlr4 protein, ratMyd88 protein, rat

Autor:innen und Institutionen

  • School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
  • Division of Plastic Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan.
  • Department of Surgery, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
  • Regeneration Medicine and Cell Therapy Research Center, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
  • Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
  • Division of Plastic Surgery, Department of Surgery, Kaohsiung Municipal Siaogang Hospital, Kaohsiung 812, Taiwan.

ORCID-Profile: Shih-Hung Wang, Shu-Hung Huang, I-Cheng Lu, Sheng-Hua Wu

Förderung

  • Ministry of Science and Technology of Taiwan
  • Kaohsiung Medical University
  • Kaohsiung Medical University Hospital
  • Kaohsiung Municipal Ta-Tung Hospital
  • Kaohsiung Municipal Siaogang Hospital
  • Childhood Burn Foundation of the Republic of China

Zitieren

APA

Wang, S. H., Huang, S. H., Hsieh, M. C., Lu, I. C., Chou, P. R., Tai, M. H., & Wu, S. H. (2023). Hyperbaric Oxygen Therapy Alleviates Paclitaxel-Induced Peripheral Neuropathy Involving Suppressing TLR4-MyD88-NF-κB Signaling Pathway. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24065379

Vancouver

Wang SH, Huang SH, Hsieh MC, Lu IC, Chou PR, Tai MH, et al. Hyperbaric Oxygen Therapy Alleviates Paclitaxel-Induced Peripheral Neuropathy Involving Suppressing TLR4-MyD88-NF-κB Signaling Pathway. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24065379

BibTeX
@article{Wang2023,
  author = {Wang, Shih-Hung and Huang, Shu-Hung and Hsieh, Meng-Chien and Lu, I-Cheng and Chou, Ping-Ruey and Tai, Ming-Hong and Wu, Sheng-Hua},
  title = {Hyperbaric Oxygen Therapy Alleviates Paclitaxel-Induced Peripheral Neuropathy Involving Suppressing TLR4-MyD88-NF-κB Signaling Pathway},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24065379}
}
Kostenlos starten →